Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | RO-3306 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | JW-480 | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | STF-62247 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | spautin-1 | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.026 | 0.7 |
mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | QS11 | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |